During the past decade, BCCA - Abbotsford Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BCCA - Abbotsford Centre" #1 sponsor was "Canadian Cancer Trials Group" with 7 trials, followed by "British Columbia Cancer Agency" with 6 trials sponsored, "NCIC Clinical Trials Group" with 5 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BCCA - Abbotsford Centre" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Oncolytics Biotech" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "BCCA - Abbotsford Centre" are "Breast Cancer" (5 trials), "Lung Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Melanoma" (1 trials) and "Advanced Non-Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "BCCA - Abbotsford Centre" in a lesser frequency.

Most popular intervention types in "BCCA - Abbotsford Centre" are "Drug" (19 trials), "Other" (6 trials), "Radiation" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pemetrexed" (2 trials), "placebo" (2 trials), "ALK qPCR assay" (1 trials) and "APBI utilizing 3D-CRT radiation" (1 trials). Other intervention names were less common.

The vast majority of trials in "BCCA - Abbotsford Centre" are 16 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "BCCA - Abbotsford Centre". 1 are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in BCCA - Abbotsford Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BCCA - Abbotsford Centre, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".